Fan Bu

Sep 20, 2024 | mdpi.com | Zhiliang Zhang |Fan Bu |Shanshan Sun |Ming Ke Ming

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jul 24, 2024 | nature.com | David Meyerholz |Fan Bu |Bin Liu |Fang Li |Stanley Perlman

AbstractAlthough Omicron RBD of SARS-CoV-2 accumulates many mutations, the backbone region (truncated RBD) of spike protein is highly conserved.

Mar 19, 2024 | onlinelibrary.wiley.com | Tara Anand |Fan Bu |Martijn J Schuemie |Marc A. Suchard

1 BACKGROUND Current guidance for specific first-line antihypertensive medication is limited, based largely on expert opinion due to lacking clinical trials comparing various medications and drug classes.1 Previously, Suchard et al.2 generated hazard ratios (HR) comparing risks for new initiators of different drug classes for various safety and effectiveness outcomes with evidence demonstrating better primary effectiveness and safety for the class of thiazides and thiazide-like diuretics,...